Managing bevacizumab-induced intraocular inflammation.
Indian J Ophthalmol
;
2012 Jul-Aug; 60(4): 311-313
Article
in English
| IMSEAR
| ID: sea-144858
ABSTRACT
The outcome of four cases of sterile endophthalmitis that developed after intravitreal injections of bevacizumab has been reported here. All four eyes received 1.25 mg/0.05 ml intravitreal bevacizumab from 0.2-ml aliquots for different etiologies. The inflammation predominantly involved the anterior chamber with mild vitreous reaction. All patients were culture negative and regained preinjection visual acuity and were culture negative following intravitreal antibiotic administration. This report highlights that intravitreal bevacizumab can cause sterile endophthalmitis and this has to be kept in mind, and clinical judgment should be used to differentiate it from infective endophthalmitis.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Uveitis
/
Aged
/
Humans
/
Male
/
Correspondence as Topic
/
Endophthalmitis
/
Communication
/
Antibodies, Monoclonal, Humanized
Language:
English
Journal:
Indian J Ophthalmol
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS